Pure Global AI
NCT06336122Recruiting

OASIS: Peer Support for T2DM in Appalachia (Peer Participant)

Older Adults Using Social Support to Improve Self-Care: Adaptation, Implementation, and Feasibility of Peer Support for Older Adults With T2DM in Appalachia.
University of KentuckyClinicalTrials.govbehavioral
Study focus
Drug/Device/Intervention
Peer Coach Training - Weekly
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
University of Kentucky
Location
Bowling Green,Hazard, United States of America
Timeline & enrollment
Phase
N/A
Start date
Feb 21, 2024
End date
Mar 31, 2026
Enrollment
76 participants
Primary outcome

Number of participants with change in A1c

Summary

The goal of this clinical trial is to compare the effects of peer coaching models in older
 adults with unmanaged type two diabetes. The main questions it aims to answer are:
 
 Are peer coaching models effective at promoting Type 2 Diabetes Mellitus self-management?
 
 If effective, which facets of the peer model are most effective? Peer coaches will Undergo
 peer coach training.
 
 Reach out to peer participants on a weekly/biweekly time frame to discuss self-management and
 goal setting.
 
 Retain records of contact, topics discussed, and general notes on interactions. Researchers
 will compare differences in the frequency of contact, as well as how peer coaches were
 matched to peer participants to see if efficacy of the intervention is altered between
 groups.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06336122
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06336122 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kentucky and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 2. Target enrollment is 76 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.